Related Experiment Videos
PFPP re-introduces DMPA
IMCH Newsletter
|January 1, 1994
Summary
Depomedroxyprogesterone acetate (DMPA), an injectable contraceptive, offers highly effective (99.7%) and safe family planning. Approved by health authorities, DMPA is a reversible method with manageable side effects for responsible parenthood.
Area of Science:
- Reproductive Health
- Pharmacology
- Public Health
Background:
- Depomedroxyprogesterone acetate (DMPA) is an injectable contraceptive re-introduced in the Philippines in 1994.
- DMPA is a synthetic progestin contraceptive administered every three months.
Purpose of the Study:
- To introduce DMPA as a new method for family planning in the Philippines.
- To inform couples about the availability and benefits of DMPA for responsible parenthood.
Main Methods:
- DMPA's mechanism of action involves inhibiting ovulation and thinning the endometrium.
- Effectiveness comparable to bilateral tubal ligation (99.7% in the first year).
Main Results:
- DMPA is medically safe, approved by US and Philippine drug authorities.
- WHO studies indicate no increased risk of cancer, congenital malformations, or infertility.
- Over 9 million women have used DMPA globally.
Conclusions:
- DMPA is a safe, reversible, and effective family planning method.
- Potential side effects like menstrual irregularities are manageable.
- DMPA introduction planned in 10 pilot areas, with wider clinic rollout to follow.